Ferozsons Laboratories Ltd 2021 AR2
The report highlights Ferozsons Laboratories Limited's operations and sustainability initiatives for the fiscal year 2020-2021. Celebrating its 60th year of listing on the Pakistan Stock Exchange, the company played a critical role in the fight against COVID-19 by manufacturing and distributing Remdesivir under license from Gilead Sciences. Ferozsons demonstrated its commitment to the UN Sustainable Development Goals through community care programs, supporting education via LUMS and TCF, and implementing environmental preservation initiatives. Additionally, the company advanced diversity and inclusion, with women constituting 43% of its Board of Directors.
Company: Ferozsons Laboratories Ltd
Sector: Health Care
Country: Pakistan
Year: 2021
Type: AR2
Pages: 192
Ferozsons Laboratories Ltd
Annual Report
The report highlights Ferozsons Laboratories Limited's operations and sustainability initiatives for the fiscal year 2020-2021. Celebrating its 60th year of listing on the Pakistan Stock Exchange, the company played a critical role in the fight against COVID-19 by manufacturing and distributing Remdesivir under license from Gilead Sciences. Ferozsons demonstrated its commitment to the UN Sustainable Development Goals through community care programs, supporting education via LUMS and TCF, and implementing environmental preservation initiatives. Additionally, the company advanced diversity and inclusion, with women constituting 43% of its Board of Directors.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jul 1, 2020 - Jun 30, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees